Double-blind, randomized, placebo-controlled, bicentric clinical investigation to evaluate the benefit and tolerability of Redusure IQP-AK-102 in reducing body weight in overweight and obese subjects
2016; Volume: 4; Issue: 3 Linguagem: Inglês
ISSN
2354-2152
AutoresUdo Bongartz, Ralf Uebelhack, Barbara Grube, Pui Lin Chong, Felix Alt,
Tópico(s)Adipokines, Inflammation, and Metabolic Diseases
Referência(s)